A 25-week, open-label trial investigating rivastigmine transdermal patches with concomitant memantine in mild-to-moderate Alzheimer’s disease: a post hoc analysis
Year: 2009
Type: article
Language: English
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Keywords: rivastigmine, transdermal patch, memantine, Alzheimer's disease, mild to moderate dementia, combination therapy, tolerability, adverse events, cognitive function, activities of daily living, global functioning, cholinesterase inhibitors, NMDA receptor antagonists, treatment discontinuation, gastrointestinal adverse effects, post hoc analysis, dose titration
Open Access status: closed
OpenAlex ID: W2111361801
